Tolerance induction after specific immunotherapy with pollen allergoids adjuvanted by monophosphoryl lipid A in children. - Wikidata - wikimedia - TriplyDB

Tolerance induction after specific immunotherapy with pollen allergoids adjuvanted by monophosphoryl lipid A in children.

Tolerance induction after specific immunotherapy with pollen allergoids adjuvanted by monophosphoryl lipid A in children.

http://www.wikidata.org/entity/Q51575029

about

New treatments for allergen immunotherapy A review of allergoid immunotherapy: is cat allergy a suitable target?SA-4-1BBL as a novel adjuvant for the development of therapeutic cancer vaccines Adjuvant activity of naturally occurring monophosphoryl lipopolysaccharide preparations from mucosa-associated bacteria Immune modulation for treatment of allergic disease.Factors influencing the allergenicity and adjuvanticity of allergens.The future of biologics: applications for food allergy.Advances in allergen immunotherapy: aiming for complete tolerance to allergens.The Potential for Emerging Microbiome-Mediated Therapeutics in Asthma.Induction of Bronchial Tolerance After 1 Cycle of Monophosphoryl-A-Adjuvanted Specific Immunotherapy in Children With Grass Pollen Allergies.New opportunities for allergen immunotherapy using synthetic peptide immuno-regulatory epitopes (SPIREs).Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells.Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy.Differential activation of dendritic cells by toll-like receptors causes diverse differentiation of naïve CD4+ T cells from allergic patients.Pollinex Quattro: an innovative four injections immunotherapy in allergic rhinitis.Safety of a proteoliposome from Neisseria meningitides as adjuvant for a house dust mite allergy vaccine.Next generation immunotherapy for tree pollen allergies.The role of basophils as innate immune regulatory cells in allergy and immunotherapy.Bronchial allergen provocation: a useful method to assess the efficacy of specific immunotherapy in children.

P2860

Q27016089-AEB03FDF-A27C-4814-91C9-43DD1A8BAA54 Q28071326-D6E8D124-558D-4683-87F7-012AE6722D19 Q36487245-34CA57CA-425F-42A4-A798-868C3631C78C Q37123782-E03221C8-A749-4488-9B7D-22D5D3ED15E5 Q37891140-FA0D184B-8C34-452C-A1AB-966A30BA19A0 Q37900649-9F936EF7-8231-4B07-980A-8E24B2DD4147 Q38348057-7F24E0C8-ED28-40D1-B8E9-C209C182F2C9 Q38391526-9A95BE6D-4538-42F9-8A10-69C85C9052C4 Q38622649-0A8D0C56-0F98-43D5-A751-60F54DCC2E37 Q38703485-820EFC44-9DA9-44A3-B8DF-01DFDE21AB3A Q38837264-404F95C5-16C5-48F2-92C0-332F4E035A2E Q39402881-EF3A0F73-A004-4978-8903-50B9F870AABB Q42153928-F2B1EB65-9427-4188-8F56-017AFE618799 Q42702885-47B66ECC-E1DD-43D7-AF07-F14A44D4A0D3 Q44240760-1F4D7B8A-883F-4A20-898C-F9FDAD1E8086 Q47836852-376A9D9E-52E7-46E6-A3DE-AA24FC2C9850 Q47884083-5B02B3C4-F7FD-4F77-A644-E6A0DA559143 Q48093883-2FAEDD2C-F1E8-443C-B800-F102815B078B Q51074147-89DD44C7-5D2F-4E40-9206-ADE6FB6BB7E4

P2860

Tolerance induction after specific immunotherapy with pollen allergoids adjuvanted by monophosphoryl lipid A in children.

http://www.wikidata.org/entity/Q51575029

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Tolerance induction after spec ...... hosphoryl lipid A in children.

@en

Tolerance induction after spec ...... hosphoryl lipid A in children.

@nl

type

label

Tolerance induction after spec ...... hosphoryl lipid A in children.

@en

Tolerance induction after spec ...... hosphoryl lipid A in children.

@nl

prefLabel

Tolerance induction after spec ...... hosphoryl lipid A in children.

@en

Tolerance induction after spec ...... hosphoryl lipid A in children.

@nl

P1433

Q51575029-6229D536-9B6C-4A3F-AC1D-EF213F11977E

P1476

Q51575029-213BF62D-6DF5-4183-80BB-335436CACFC1

P2093

Q51575029-380F8547-CC07-4771-8659-3B2206CF9F3F

Q51575029-A9AAD2DA-1984-48C3-BC04-DC3C627FD5A6

Q51575029-B46A7026-5C7E-4DA9-8207-BD64F56912C5

Q51575029-B4DDF71D-033D-4D65-862D-EAB4002F18E9

Q51575029-C2FAD56A-58F0-4B3C-811D-09D5B383A79A

Q51575029-CD5A761F-647D-4A9B-9615-C2DDE3390A6B

Q51575029-E4BA2208-4EE2-416D-8BD0-F16E378B1F6A

P2860

Q51575029-0900364C-945B-44A4-B23E-FA630840DE40

Q51575029-0ADA2733-9B3C-4382-B479-39662A6CA144

Q51575029-0EFF2C08-7242-4F34-99D8-C89829014655

Q51575029-10F99E98-D035-4775-98D9-AA528469DECA

Q51575029-13024F68-7CB6-4924-9E06-B7471B532166

Q51575029-1A6BFDA2-6EDF-4459-AD59-39BE6D5FEBF2

Q51575029-20222A33-195B-4E3C-B025-93C8F6C48050

Q51575029-2550B9E6-775B-4B90-B1A0-F9B7EA28E751

Q51575029-25AB0B5E-D34F-4436-B902-959AF0CCB69E

Q51575029-2904F2C4-779D-4676-B44B-F042B100D1C5

P304

Q51575029-E3D4CC72-54D2-4B1F-A141-85DE7F4CAAA1

P31

Q51575029-33689C82-2A85-4894-A395-3DE25A555AAD

P356

Q51575029-406BB29B-5870-4E77-80F9-2E0E4FA6A21A

P433

Q51575029-307EDCEF-09D4-40A0-B475-53509FD775F9

P478

Q51575029-14F4C15A-25D3-4763-A714-4DA18D78249F

P577

Q51575029-AC38C623-4A4C-4F15-ACC8-0CE236BA10AD

P5875

Q51575029-594B8C96-BA47-4771-B696-27B884943BAB

P698

Q51575029-9A2B0ECB-BB9C-4116-B4D9-E8A0B33F4037

P921

Q51575029-2D8F719A-2B1B-4347-A2BC-354AA84461DC

Q51575029-AE3B3CB9-0F33-45F8-B8F5-BCA6B3A46172

P932

Q51575029-81294877-BBD1-491D-862C-A79CB94B3C6B

P356

J.1365-2249.2010.04106.X

P1433

Clinical and Experimental Immunology

P1476

Tolerance induction after spec ...... hosphoryl lipid A in children.

@en

P2093

J Schulze

http://www.w3.org/2001/XMLSchema#string

M A Rose

http://www.w3.org/2001/XMLSchema#string

M Rosewich

http://www.w3.org/2001/XMLSchema#string

O Eickmeier

http://www.w3.org/2001/XMLSchema#string

R Schubert

http://www.w3.org/2001/XMLSchema#string

S Zielen

http://www.w3.org/2001/XMLSchema#string

T Telles

http://www.w3.org/2001/XMLSchema#string

P2860

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC)

Monophosphoryl lipid A (MPL) formulations for the next generation of vaccines.

Long-term clinical efficacy of grass-pollen immunotherapy.

Mechanisms of allergen-specific immunotherapy.

Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study.

CD4(+) regulatory T cells.

Immune mechanisms of allergen-specific sublingual immunotherapy.

Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy.

P304

403-410

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2249.2010.04106.X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

160

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42608717

http://www.w3.org/2001/XMLSchema#string

P698

20345983

http://www.w3.org/2001/XMLSchema#string

P921

P932

2883111

http://www.w3.org/2001/XMLSchema#string